JENBURKT PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Jenburkt Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.83₹ -31.60
As on Dec 17, 2025, 3:00 PM IST
Jenburkt Pharmaceuticals Price Performance
Today's LowToday's High
₹1,075.15₹1,114.00
₹1,084.00
52 Weeks' Low52 Weeks' High
₹936.70₹1,410.00
₹1,084.00
Open Price
₹1,110.00
Prev. Close
₹1,115.60
Volume
392
Over the last 5 years, the share price of Jenburkt Pharmaceuticals has gained 20.08% CAGR. Over the past year, the corresponding return has been -18.29%.
Jenburkt Pharmaceuticals’s current P/E of 14.50x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Jenburkt Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Jenburkt Pharmaceuticals | -0.43 | -12.24 | -2.87 | -18.64 | -18.29 | 18.28 | 20.08 |
| Sun Pharmaceutical Industries | 0.55 | 1.83 | 10.85 | 8.92 | 0.36 | 22.03 | 25.73 |
| Divi's Laboratories | 0.13 | -3.41 | 4.14 | -3.61 | 7.73 | 23.43 | 10.47 |
| Torrent Pharmaceuticals | -0.48 | -1.1 | 6.52 | 16.07 | 11.67 | 33.14 | 22.27 |
| Cipla | 0.5 | -2.58 | -4.02 | -0.46 | 3.18 | 10.9 | 13.81 |
| Dr. Reddy's Laboratories | 1.8 | 2.34 | -2.85 | -3.44 | 2.05 | 13.11 | 4.63 |
| Lupin | 2.91 | 3.08 | 4.12 | 8.82 | 3.37 | 42.53 | 16.8 |
| Zydus Lifesciences | -0.44 | -1.57 | -11.13 | -4.09 | -5.14 | 30.85 | 14.06 |
| Mankind Pharma | -1.4 | -5.68 | -17.57 | -9.99 | -20.43 | 14.01 | 8.18 |
| Aurobindo Pharma | 2.06 | -3.37 | 9.05 | 7.75 | -1.48 | 39.65 | 6.46 |
| Alkem Laboratories | 0.58 | -1.62 | 2.83 | 16.99 | 4.49 | 23.2 | 13.83 |
| Abbott India | -0.98 | -6.24 | -10.32 | -12.73 | -0.91 | 9.91 | 11.47 |
| Glenmark Pharmaceuticals | -0.11 | 4.57 | -4.47 | 17.96 | 28.97 | 67.2 | 30.34 |
| Laurus Labs | -0.71 | -1.11 | 13.15 | 53.04 | 76.95 | 37.51 | 24.13 |
| Biocon | 2.03 | -8.22 | 9.1 | 9.67 | 10.2 | 13.62 | -3.5 |
| GlaxoSmithKline Pharmaceuticals | -0.32 | 3.69 | -5.57 | -20.58 | 14.06 | 24.72 | 10.25 |
| Anthem Biosciences | 3.4 | 0.1 | -22.86 | -8.8 | -8.8 | -3.01 | -1.82 |
| Ipca Laboratories | -4.81 | -4.73 | 6.25 | 2.72 | -10.53 | 17.58 | 5.13 |
| Ajanta Pharma | -2.08 | 3.86 | 1.5 | 2.1 | -9.5 | 30.12 | 18.66 |
| J B Chemicals & Pharmaceuticals | -0.89 | -1.48 | 5.96 | 4.01 | -1.79 | 20.36 | 27.18 |
Over the last one year, Jenburkt Pharmaceuticals has declined 18.29% compared to peers like Sun Pharmaceutical Industries (0.36%), Divi's Laboratories (7.73%), Torrent Pharmaceuticals (11.67%). From a 5 year perspective, Jenburkt Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (25.73%) and Divi's Laboratories (10.47%).
Jenburkt Pharmaceuticals Financials
Jenburkt Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,079.69 | 1,100.95 |
| 10 | 1,101.62 | 1,107.38 |
| 20 | 1,157.13 | 1,128.75 |
| 50 | 1,139.22 | 1,144.59 |
| 100 | 1,155.04 | 1,152.05 |
| 200 | 1,145.01 | 1,141.43 |
Jenburkt Pharmaceuticals Share Holding Pattern
In the latest quarter, Jenburkt Pharmaceuticals saw a drop in promoter holding to 46.66%, while DII stake unchanged at 0.12%, FII holding unchanged at 0.00%, and public shareholding moved up to 53.22% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Jenburkt Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 28, 2025, 10:30 PM IST | Jenburkt Pharmac - Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2025. |
| Oct 28, 2025, 10:19 PM IST | Jenburkt Pharmac - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 28Th October, 2025. |
| Oct 09, 2025, 6:42 PM IST | Jenburkt Pharmac - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 03, 2025, 6:37 PM IST | Jenburkt Pharmac - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quar |
| Aug 12, 2025, 11:09 PM IST | Jenburkt Pharmac - Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2025. |
About Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 10/06/1985 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1985PLC036541 and registration number is 036541. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 151.69 Cr. and Equity Capital is Rs. 4.41 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressNirmala Apartments, Mumbai Maharashtra 400058
- Contact
Management
- Mr. Ashish U BhutaChairman & Managing Director
- Mr. Dilip H BhutaWholeTime Director & CFO
- Mrs. Hina R MehtaInd. Non-Executive Director
- Mr. Sumit A ThakkarInd. Non-Executive Director
- Mr. Krishnan SubharamanInd. Non-Executive Director
- Mr. Pankaj A DantwalaInd. Non-Executive Director
FAQs on Jenburkt Pharmaceuticals Share Price
What is the share price of Jenburkt Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Jenburkt Pharmaceuticals is ₹1,084.00 as on Dec 17, 2025.
What kind of stock is Jenburkt Pharmaceuticals?
The Jenburkt Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Jenburkt Pharmaceuticals?
The market cap of Jenburkt Pharmaceuticals is ₹478.40 Cr as on Dec 17, 2025.
What are today's High and Low prices of Jenburkt Pharmaceuticals?
Today’s highest and lowest price of Jenburkt Pharmaceuticals are ₹1,114.00 and ₹1,075.15.
What are the 52 Week High and 52 Week Low of Jenburkt Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Jenburkt Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Jenburkt Pharmaceuticals is ₹1,410.00 and 52-week low of Jenburkt Pharmaceuticals is ₹936.70 as on Dec 17, 2025.
How has the Jenburkt Pharmaceuticals performed historically in terms of returns?
The Jenburkt Pharmaceuticals has shown returns of -2.83% over the past day, -12.24% for the past month, -2.87% over 3 months, -18.29% over 1 year, 18.28% across 3 years, and 20.08% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Jenburkt Pharmaceuticals?
P/E ratio of and PB ratio of Jenburkt Pharmaceuticals are 14.50 and 2.79 on Dec 17, 2025. While the company gives a dividend yield of 1.66 per annum.
✕
Market Pulse